Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

被引：0
作者：
Johan Jendle
Jayne Smith-Palmer
Alexis Delbaere
Simona de Portu
Natalie Papo
William Valentine
Stéphane Roze
机构：
[1] Örebro University,
[2] Ossian Health Economics and Communications,undefined
[3] Medtronic International Trading Sarl,undefined
[4] HEVA HEOR,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Cost; Cost-effectiveness; Type 1 diabetes; Sensor-augmented pump therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1030
页数：15
相关论文
共 50 条
  • [21] Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial
    Azahaf, Salima
    Beunen, Kaat
    Van Wilder, Nancy
    Ballaux, Dominique
    Vanhaverbeke, Gerd
    Taes, Youri
    Aers, Xavier-Philippe
    Nobels, Frank
    Van Huffel, Liesbeth
    Marlier, Joke
    Lee, Dahae
    Cuypers, Joke
    Preumont, Vanessa
    Siegelaar, Sarah E.
    Painter, Rebecca C.
    Laenen, Annouschka
    Gillard, Pieter
    Mathieu, Chantal
    Luyten, Jeroen
    Benhalima, Katrien
    [J]. ECLINICALMEDICINE, 2025, 81
  • [22] Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems
    Tauschmann, Martin
    Hovorka, Roman
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (06) : 943 - 955
  • [23] Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
    Braendle, M.
    Erny-Albrecht, K. M.
    Goodall, G.
    Spinas, G. A.
    Streit, P.
    Valentine, W. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (08) : 501 - 515
  • [24] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [25] Sensor-Augmented Pump Therapy: description of pediatric patients with Type 1 Diabetes Mellitus (T1D) and initial metabolic outcomes
    Wong Lam, Carolina
    Hurtado Navarro, Josefa
    Fuentes Diaz, Rocio
    Toro Toro, Elizabeth
    Reyes Espejo, Barbara
    [J]. ANDES PEDIATRICA, 2022, 93 (06): : 860 - 867
  • [26] Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective
    Marc Evans
    Jens Gundgaard
    Brian Bekker Hansen
    [J]. Diabetes Therapy, 2016, 7 : 809 - 823
  • [27] Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
    Monika Russel-Szymczyk
    Vasil Valov
    Alexandra Savova
    Manoela Manova
    [J]. BMC Endocrine Disorders, 19
  • [28] Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective
    Evans, Marc
    Gundgaard, Jens
    Hansen, Brian Bekker
    [J]. DIABETES THERAPY, 2016, 7 (04) : 809 - 823
  • [29] Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
    Russel-Szymczyk, Monika
    Valov, Vasil
    Savova, Alexandra
    Manova, Manoela
    [J]. BMC ENDOCRINE DISORDERS, 2019, 19 (01)
  • [30] Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer's perspective
    Permsuwan, Unchalee
    Thavorn, Kednapa
    Dilokthornsakul, Piyameth
    Saokaew, Surasak
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (09) : 991 - 999
12345